Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Gross Profit: 2010-2024

Historic Gross Profit for Whitehawk Therapeutics (WHWK) over the last 12 years, with Dec 2024 value amounting to $23.0 million.

  • Whitehawk Therapeutics' Gross Profit rose 35.82% to $6.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $24.6 million, marking a year-over-year increase of 17.86%. This contributed to the annual value of $23.0 million for FY2024, which is 6.56% up from last year.
  • As of FY2024, Whitehawk Therapeutics' Gross Profit stood at $23.0 million, which was up 6.56% from $21.5 million recorded in FY2023.
  • Over the past 5 years, Whitehawk Therapeutics' Gross Profit peaked at $23.0 million during FY2024, and registered a low of $13.9 million during FY2022.
  • Over the past 3 years, Whitehawk Therapeutics' median Gross Profit value was $21.5 million (recorded in 2023), while the average stood at $19.5 million.
  • Its Gross Profit has fluctuated over the past 5 years, first dropped by 0.85% in 2022, then soared by 55.21% in 2023.
  • Over the past 5 years, Whitehawk Therapeutics' Gross Profit (Yearly) stood at $14.0 million in 2020, then remained steady at $14.0 million in 2021, then declined by 0.85% to $13.9 million in 2022, then skyrocketed by 55.21% to $21.5 million in 2023, then climbed by 6.56% to $23.0 million in 2024.